Please use this identifier to cite or link to this item:
Type: Outro documento
Title: Drugging the kinome
Author: Axtman, A. D.
Couñago, R.
Drewry, D. H.
Robers, M. B.
Wells, C. I.
Abstract: Kinases are perhaps the most successfully drugged target families of the 21st century, with 35 FDA approved medicines. These drugs only target a very small percentage of the human kinome. Tools that allow exploration of the rest of the kinome will no doubt lead to the identification of new validated kinase drug targets and new approved medicines. In this chapter we describe the progress towards drugging the kinome by talking about 4 groups of kinases: kinases currently targeted by FDA approved drugs, kinases targeted by potent and selective chemical probes, kinases for which there are narrow spectrum inhibitors available ("covered" kinases), and then the remaining kinases for which there are currently no narrow spectrum inhibitors available ("uncovered" kinases). We believe that the scientific community has the motivation, opportunity, and ability to parlay the collective experience and wealth of kinase data available into a set of molecules that cover the entire kinome and can be used to identify the next generation of important therapeutic kinase targets
Subject: Fosfotransferases
Estrutura de cristal
Base de conhecimento
Country: Reino Unido
Editor: Royal Society of Chemistry
Rights: Fechado
Identifier DOI: 10.1039/9781788013093-00253
Date Issue: 2019
Appears in Collections:IB - Artigos e Outros Documentos

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.